Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Income from Continuing Operations (2018 - 2025)

AVITA Medical's Income from Continuing Operations history spans 8 years, with the latest figure at 11621000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 123.15% year-over-year to 11621000.0; the TTM value through Dec 2025 reached 48587000.0, down 72417.91%, while the annual FY2025 figure was 48587000.0, 72417.91% down from the prior year.
  • Income from Continuing Operations reached 11621000.0 in Q4 2025 per RCEL's latest filing, up from 13187000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 50189000.0 in Q4 2024 to a low of 18658000.0 in Q1 2024.
  • Average Income from Continuing Operations over 5 years is 4358263.16, with a median of 9220000.0 recorded in 2023.
  • Peak YoY movement for Income from Continuing Operations: surged 785.6% in 2023, then plummeted 123.15% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 5948000.0 in 2021, then grew by 7.73% to 5488000.0 in 2022, then soared by 785.6% to 37626000.0 in 2023, then soared by 33.39% to 50189000.0 in 2024, then crashed by 123.15% to 11621000.0 in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Income from Continuing Operations are 11621000.0 (Q4 2025), 13187000.0 (Q3 2025), and 9920000.0 (Q2 2025).